Monthly production to see surge: Covishield to reach 120 million, Covaxin to 58 million per month

‘Mission COVID Suraksha- the Indian COVID-19 Vaccine Development Mission’ has been launched by Department of Biotechnology under the Ministry of Science and Technology. The initiative has been launched with sole aim of supporting vaccine production in India. The Mission is being implemented by the Biotechnology Industry Research Assistance Council (BIRAC), which is a public sector undertaking (PSU) of the Department of Biotechnology.  Covishield’s monthly production is projected to increase to over 120 million doses while that of Covaxin will increase to 58 million doses by month of December. The information was told in Rajya Sabha by the government on Tuesday. ‘Mission COVID Suraksha- the Indian COVID-19 Vaccine Development Mission’ has been launched by Department of Biotechnology under the Ministry of Science and Technology. The initiative has been launched with sole aim of supporting vaccine production in India. The Mission is being implemented by the Biotechnology Industry Research Assistance Council (BIRAC), which is a public sector undertaking (PSU) of the Department of Biotechnology.  Covishield’s monthly production is projected to increase to over 120 million doses while that of Covaxin will increase to 58 million doses by month of December. The information was told in Rajya Sabha by the government on Tuesday.  […]